Endra Life Sciences Inc (NDRA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NDRA Annual Balance Sheets →
Tracking balance sheet results across Endra Life Sciences Inc to Jun 30 2025 helps illustrate how Jun 30 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1.74
Cash, Cash Equivalents Other3.80
Cash & Short-term Investments4.00
Other Current Assets0.00
Prepaid Expense, Current AS0.05
Total Current Assets5.59
Equipment/Property/Plant Net0.04
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR0.00
Other Assets, Noncurrent2.31
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Operating Lease Right Of Use Asset0.43
Total Assets7.94
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.65
Accounts Payable and Accrued Liabilities LI0.01
Other Liabilities, Current0.13
Total Current Liabilities0.79
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.56
Other liabilities, Noncurrent0.29
Operating Lease Liability Current0.13
Operating Lease Liability Noncurrent0.33
Total Liabilities1.63
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock118.00
Retained Earnings / Accumulated Deficit-111.62
Other Equity0.00
Common Stockholder's Equity6.31
Total Stockholder's Equity6.31
Liabilities & Stockholder's Equity7.94
4 historic quarters locked

Sign in to unlock the full Endra Life Sciences Inc balance sheet history.

About Endra Life Sciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-090027

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.